ALLROCK Trademark

Trademark Overview

On Tuesday, July 16, 2024, a trademark application was filed for ALLROCK with the United States Patent and Trademark Office. The USPTO has given the ALLROCK trademark a serial number of 98650614. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, September 23, 2025. This trademark is owned by ALLROCK BIO, INC.. The ALLROCK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
allrock

General Information

Serial Number98650614
Word MarkALLROCK
Filing DateTuesday, July 16, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, September 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2025

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, July 16, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameALLROCK BIO, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45208
Party NameALLROCK BIO, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45208

Trademark Events

Event DateEvent Description
Tuesday, July 16, 2024NEW APPLICATION ENTERED
Wednesday, January 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 28, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 28, 2025ASSIGNED TO EXAMINER
Wednesday, February 12, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 18, 2025PUBLISHED FOR OPPOSITION
Friday, April 11, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, February 18, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, April 11, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 11, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 11, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 15, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 23, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, September 23, 2025SOU EXTENSION 1 FILED
Tuesday, September 23, 2025SOU EXTENSION 1 GRANTED
Wednesday, September 24, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 1, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, August 1, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 1, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 1, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

allrock fields biotechnology pharmaceutical development research